Mrs. Andreea-Liana Bot Rachisan, Romania
Novel biomarkers predictive for graft dysfunction – a pilot study using machine learning prediction as an AI tool
Dr. Vikas Dharnidharka, United States
Contemporary treatment responses of recurrent focal segmental glomerulosclerosis or steroid resistant nephrotic syndrome in children after kidney transplantation: Phase 2 of a multicenter electronic health record data analysis
Dr. Lucy McAvoy, United Kingdom
Positive impact on graft function with repeated courses of Bortezomib in antibody-mediated rejection in a pediatric renal transplant recipient
Helen Pizzo, United States
Low incidence of rejection and de novo donor-specific antibody formation following covid-19 vaccination or infection among pediatric kidney transplant recipients
Dr. Moran Plonsky Toder, Israel
Phenotypic expansion of CRB2-related disease in monozygotic twins with multisystem involvement and severe post-transplant complications: Case report and literature review
Dr. Haider Ali, Pakistan
Living donor liver transplantation outcomes in Pediatric patients with liver decompensation secondary to Budd-Chiari Syndrome: A single center experience.
Dr. Syed Muhammad Talha Bukhari, Pakistan
Auxiliary Partial Orthotopic Liver Transplantation (APOLT) in Pediatric Patients with Crigler-Najjar Syndrome: A Single-Center Experience
Dr. Luca della Volpe, Italy
Changes in plasma citrulline after liver transplantation in patients with inborn errors of metabolism: non-invasive recovery indicator of intestinal function?
Dr. Małgorzata Markiewicz-Kijewska, Poland
Uncommon but Fatal: Early Immunological Complications After Pediatric Liver Transplantation and Their Impact on Survival
Mrs. Amy Andrews, New Zealand
Use of parenteral nutrition prior to heart transplantation for Protein-losing enteropathy related to Fontan circulation: patient and clinician perspectives at critical timepoints
Ji Soo Kim, United Kingdom
Investigating the modifiable psychosocial variables influencing access to and outcomes after kidney transplantation in children: preliminary findings of a longitudinal study
Dr. Jianxin Xi, People's Republic of China
Perioperative efficacy study of recombinant humanized anti-CD25 monoclonal antibody for immunoinduction in pediatric liver transplant recipients